Directory
>
Aleks Radovic-Moreno
Aleks Radovic-Moreno
Co-Founder, Founding Investor | Be Biopharma
Boston, Massachusetts, United States
Aleks Radovic-Moreno
Summary
Aleks Radovic-Moreno is a seasoned partner at Longwood Fund, with a robust background in biomedical engineering and biotechnology. He co-founded over five biotech companies, including Vor Bio and Alivio, where he led substantial fundraising efforts and operational strategies. His innovative contributions in drug development include being the lead inventor of AST-008, a TLR9 agonist currently in Phase 2 trials. With a strong publication record, including articles in prestigious journals like Science and PNAS, Aleks combines scientific acumen with entrepreneurial spirit. A cancer survivor, he is passionate about advancing healthcare solutions and raising awareness for sarcoma. His journey reflects a unique blend of scientific rigor and business savvy, making him a key player in the biotech landscape.
Aleks Radovic-Moreno
Work Experience
Co-Founder, Founding Investor at
Be Biopharma
October 2020 - Present
Partner at
Longwood Partners, L.P.
December 2019 - Present
Senior Vice President at
PureTech Health
January 2015 - December 2019
Co-Founder at
Alivio Therapeutics, Inc.
May 2016 - December 2019
Co-Founder at
Vor Biopharma Inc.
May 2016 - August 2019
Research Scientist at
Exicure
January 2013 - December 2014
Intern at
SR One Capital Management
July 2011 - September 2011
Venture Partner at
Longwood Fund
Present
Aleks Radovic-Moreno
Education
Massachusetts Institute of Technology, Doctor Of Philosophy (Ph.D.)
January 2005 - January 2012
January 2005 - January 2012
Penn State University, Bachelor Of Science (Bs)
January 2001 - January 2005
Frequently Asked Questions about Aleks Radovic-Moreno
What is Aleks Radovic-Moreno email address?
Aleks Radovic-Moreno's primary email address is *****@longwoodfund.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Aleks Radovic-Moreno work for?
Aleks Radovic-Moreno is a Co-Founder, Founding Investor at Be Biopharma.
Where Aleks Radovic-Moreno graduated from?
Aleks Radovic-Moreno holds a degree in Chemical And Biomedical Engineering from Massachusetts Institute of Technology.
How can I directly contact Aleks Radovic-Moreno?
To contact Aleks Radovic-Moreno directly, you can use the email address *****@longwoodfund.com. Complete contact information is available upon registration with Muraena.
Who is Aleks Radovic-Moreno?
Aleks Radovic-Moreno is a seasoned partner at Longwood Fund, with a robust background in biomedical engineering and biotechnology. He co-founded over five biotech companies, including Vor Bio and Alivio, where he led substantial fundraising efforts and operational strategies. His innovative contributions in drug development include being the lead inventor of AST-008, a TLR9 agonist currently in Phase 2 trials. With a strong publication record, including articles in prestigious journals like Science and PNAS, Aleks combines scientific acumen with entrepreneurial spirit. A cancer survivor, he is passionate about advancing healthcare solutions and raising awareness for sarcoma. His journey reflects a unique blend of scientific rigor and business savvy, making him a key player in the biotech landscape.
Aleks`s contact details
*****@longwoodfund.com
**************@be.bio
Colleagues
Entrepreneur In Residence
Chief Scientific Officer
Chief Executive Officer